Imgen BioSciences, Inc. (Imgen) is a biotechnology company focused on the discovery and development of immunotherapeutic and diagnostic agents/techniques in the fields of cancer, infectious diseases, and food safety rapid tests. The company also provides services on molecular biology and biochemistry areas.

News

Imgen's Founder and President Dr. Wendell Yang granted a first patent on TCR-CAR-T(Tcar-T) related technology in Australia. April, 2022 [PDF]

Imgen's Founder and President Dr. Wendell Yang’s PCT patent application on TCR-CAR-T(Tcar-T) related technology published. Jan., 2021 [PDF]

Imgen's Founder and President Dr. Wendell Yang as a first inventor granted another US patent on CAR-T related technology. Dec., 2020 [PDF]

Imgen's Founder and President Dr. Wendell Yang as a first inventor granted a US patent on CAR-T related technology. Dec., 2015 [PDF]

Biomanufacturing keeps moving along on SouthCoast. Sept., 2014 [PDF]

Imgen supports Massachusetts Life Sciences Center Internship 2013 [PDF]